Report ID: SQMIG35E2011
In-Vitro Colorectal Cancer Screening Tests Market Size, Share, Growth Analysis, By Test Type (Fecal Occult Blood Tests, Biomarker Tests), By End User (Hospitals, Clinics), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35E2011 |
Region:
Global |
Published Date: October, 2024
Pages:
200
|
Tables:
72 |
Figures:
75
In-Vitro Colorectal Cancer Screening Tests Market Competitive Landscape
The existence of several international players defines the global market. To increase their market share, businesses use a variety of techniques, including partnerships, agreements, regional growth, mergers, acquisitions, and new product creation. In our in-vitro colorectal cancer screening tests market reports, some of the leading quality in-vitro colorectal cancer screening tests manufacturers are as follows: Abbott (US), F. Hoffmann-La Roche AG (Switzerland), Quest Diagnostics (US), Sysmex Corporation (Japan), Siemens Healthcare (Germany), Alere Inc. (US), Eiken Chemical (Japan), Siemens AG (Germany), OncoCyte Corporation-Biotime (US), Merck KGaA (Germany).
Top Players in the Global In-Vitro Colorectal Cancer Screening Tests Market
- Abbott Laboratories
- Beckman Coulter Inc
- Eiken Chemical Co., Ltd.
- Epigenomics
- Sysmex Corporation
- Siemens Healthcare GmbH
- Quest Diagnostics Incorporated
- OncoCyte Corporation
- Merck KGaA
- Immunostics Inc.
- Kyowa Kirin Co. Ltd.
- Randox Laboratories Ltd.
- R-Biopharm AG
- Bio-Rad Laboratories, Inc
- Exact Sciences Corporation
- F. Hoffmann-La Roche AG
- Genomic Health, Inc
- Hologic, Inc.
- Illumina, Inc.
- Invitae Corporation
In-Vitro Colorectal Cancer Screening Tests Market
In-Vitro Colorectal Cancer Screening Tests Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
